Literature DB >> 25035205

Random forests to predict rectal toxicity following prostate cancer radiation therapy.

Juan D Ospina1, Jian Zhu2, Ciprian Chira3, Alberto Bossi4, Jean B Delobel3, Véronique Beckendorf5, Bernard Dubray6, Jean-Léon Lagrange7, Juan C Correa8, Antoine Simon9, Oscar Acosta10, Renaud de Crevoisier11.   

Abstract

PURPOSE: To propose a random forest normal tissue complication probability (RF-NTCP) model to predict late rectal toxicity following prostate cancer radiation therapy, and to compare its performance to that of classic NTCP models. METHODS AND MATERIALS: Clinical data and dose-volume histograms (DVH) were collected from 261 patients who received 3-dimensional conformal radiation therapy for prostate cancer with at least 5 years of follow-up. The series was split 1000 times into training and validation cohorts. A RF was trained to predict the risk of 5-year overall rectal toxicity and bleeding. Parameters of the Lyman-Kutcher-Burman (LKB) model were identified and a logistic regression model was fit. The performance of all the models was assessed by computing the area under the receiving operating characteristic curve (AUC).
RESULTS: The 5-year grade ≥2 overall rectal toxicity and grade ≥1 and grade ≥2 rectal bleeding rates were 16%, 25%, and 10%, respectively. Predictive capabilities were obtained using the RF-NTCP model for all 3 toxicity endpoints, including both the training and validation cohorts. The age and use of anticoagulants were found to be predictors of rectal bleeding. The AUC for RF-NTCP ranged from 0.66 to 0.76, depending on the toxicity endpoint. The AUC values for the LKB-NTCP were statistically significantly inferior, ranging from 0.62 to 0.69.
CONCLUSIONS: The RF-NTCP model may be a useful new tool in predicting late rectal toxicity, including variables other than DVH, and thus appears as a strong competitor to classic NTCP models.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25035205     DOI: 10.1016/j.ijrobp.2014.04.027

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Rectal bleeding after radiation therapy for endometrial cancer.

Authors:  Devarati Mitra; Remi Nout; Paul J Catalano; Carien Creutzberg; Nicole Cimbak; Larissa Lee; Akila N Viswanathan
Journal:  Radiother Oncol       Date:  2015-05-20       Impact factor: 6.280

2.  Feasibility study of individualized optimal positioning selection for left-sided whole breast radiotherapy: DIBH or prone.

Authors:  Hui Lin; Tianyu Liu; Chengyu Shi; Saskia Petillion; Isabelle Kindts; Caroline Weltens; Tom Depuydt; Yulin Song; Ziad Saleh; Xie George Xu; Xiaoli Tang
Journal:  J Appl Clin Med Phys       Date:  2018-02-13       Impact factor: 2.102

3.  Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer.

Authors:  Oscar Casares-Magaz; Ludvig Paul Muren; Vitali Moiseenko; Stine E Petersen; Niclas Johan Pettersson; Morten Høyer; Joseph O Deasy; Maria Thor
Journal:  Acta Oncol       Date:  2017-09-08       Impact factor: 4.089

4.  Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.

Authors:  Vittoria D'Avino; Giuseppe Palma; Raffaele Liuzzi; Manuel Conson; Francesca Doria; Marco Salvatore; Roberto Pacelli; Laura Cella
Journal:  Radiat Oncol       Date:  2015-04-08       Impact factor: 3.481

5.  The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning.

Authors:  Jian Zhu; Antoine Simon; Pascal Haigron; Caroline Lafond; Oscar Acosta; Huazhong Shu; Joel Castelli; Baosheng Li; Renaud De Crevoisier
Journal:  Onco Targets Ther       Date:  2016-12-12       Impact factor: 4.147

6.  Nomogram to predict rectal toxicity following prostate cancer radiotherapy.

Authors:  Jean-Bernard Delobel; Khemara Gnep; Juan David Ospina; Véronique Beckendorf; Ciprian Chira; Jian Zhu; Alberto Bossi; Taha Messai; Oscar Acosta; Joël Castelli; Renaud de Crevoisier
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

7.  Investigating rectal toxicity associated dosimetric features with deformable accumulated rectal surface dose maps for cervical cancer radiotherapy.

Authors:  Jiawei Chen; Haibin Chen; Zichun Zhong; Zhuoyu Wang; Brian Hrycushko; Linghong Zhou; Steve Jiang; Kevin Albuquerque; Xuejun Gu; Xin Zhen
Journal:  Radiat Oncol       Date:  2018-07-06       Impact factor: 3.481

8.  Evaluating the predictive value of quantec rectum tolerance dose suggestions on acute rectal toxicity in prostate carcinoma patients treated with IMRT.

Authors:  E Elif Ozkan; Alper Ozseven; Z Arda Kaymak Cerkesli
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-09

9.  Design and Selection of Machine Learning Methods Using Radiomics and Dosiomics for Normal Tissue Complication Probability Modeling of Xerostomia.

Authors:  Hubert S Gabryś; Florian Buettner; Florian Sterzing; Henrik Hauswald; Mark Bangert
Journal:  Front Oncol       Date:  2018-03-05       Impact factor: 6.244

10.  Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.

Authors:  Muhammad Ammad-Ud-Din; Suleiman A Khan; Krister Wennerberg; Tero Aittokallio
Journal:  Bioinformatics       Date:  2017-07-15       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.